Spencer Lee Reeder, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8200 Bryan Dairy Rd Ste 340, Largo, FL 33777 Phone: 727-393-5728 |
Carmen Zoila Romero Mulino, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 8200 Bryan Dairy Rd Ste 340, Largo, FL 33777 Phone: 727-398-5728 |
Dr. Megan Marie Farina, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8200 Bryan Dairy Rd Ste 340, Largo, FL 33777 Phone: 727-398-5728 |
Kelly Jo Dyson, M.A., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 11200 Seminole Blvd Ste 301, Largo, FL 33778 Phone: 727-977-5222 |
Dr. Alyssa Steinweis Vanderveen, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8200 Bryan Dairy Rd Ste 340, Largo, FL 33777 Phone: 727-398-5728 |
Ryan Malkiewicz, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 8200 Bryan Dairy Rd, Suite 340, Largo, FL 33777 Phone: 727-398-5428 |
Elizabeth Anne Napolitano, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1301 2nd Ave Sw, Largo, FL 33770 Phone: 727-341-0551 |
News Archive
A new paper published online in the Annals of the American Thoracic Society provides a roadmap that critical care clinicians' professional societies can use to address burnout.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person's susceptibility to depression, activates a serotonin receptor in the brain known for producing
Abbott announced today that it will expand its existing agreement with GlaxoSmithKline Biologicals S.A. to include the development of an additional companion diagnostic test in support of GSK's cancer immunotherapy research program.
› Verified 2 days ago